SC
JAZZ icon

SummitTX Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

SummitTX Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.74M Sell
36,276
-36,946
-50% -$8.09M 0.23% 110
2026
Q1 		$13.8M Sell
73,222
-53,573
-42% -$9.36M 0.43% 37
2025
Q4 		$21.6M Buy
126,795
+103,790
+451% +$15.9M 0.65% 22
2025
Q3 		$3.03M Sell
23,005
-9,135
-28% -$1.1M 0.13% 182
2025
Q2 		$3.41M Buy
32,140
+17,740
+123% +$1.93M 0.15% 168
2025
Q1 		$1.79M Buy
+14,400
New +$1.88M 0.08% 271

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

SummitTX Capital's JAZZ Position: Q2 2026 in Review

SummitTX Capital reduced its Jazz Pharmaceuticals (JAZZ) stake by 50% in Q2 2026, selling an estimated $8.09M and leaving 36,276 shares worth $8.74M. The position accounts for 0.23% of the portfolio, ranked #110.

SummitTX Capital first reported a position in JAZZ in Q1 2025 and has held it in 6 quarters since. The position peaked at $21.6M in Q4 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • SummitTX Capital held 36,276 shares of Jazz Pharmaceuticals worth $8.74M as of Q2 2026.
  • SummitTX Capital sold 36,946 Jazz Pharmaceuticals shares in Q2 2026, an estimated $8.09M.
  • Jazz Pharmaceuticals made up 0.23% of SummitTX Capital's portfolio in Q2 2026, its #110 holding.
  • SummitTX Capital first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • SummitTX Capital's Jazz Pharmaceuticals position peaked at $21.6M in Q4 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.